ArticleCureus2026
Severe Hypokalemia and Life-Threatening Ventricular Arrhythmias: A Case of Normotensive Primary Aldosteronism.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary aldosteronism (PA), the most common cause of secondary hypertension, is characterized by autonomous adrenal aldosterone overproduction independent of the renin-angiotensin system, resulting in sodium retention, potassium wasting, and cardiovascular sequelae that exceed the risk attributable to blood pressure elevation alone. Although hypertension is the predominant clinical manifestation, PA may also present without hypertension or hypokalemia, making atypical presentations a significant diagnostic challenge. Aldosterone-mediated myocardial fibrosis combined with hypokalemia-driven electrophysiologic instability can precipitate life-threatening ventricular arrhythmias that may constitute the dominant clinical presentation in the absence of classic features. We present a case of normotensive PA in which diagnostic delay resulted in recurrent ventricular arrhythmias and sudden cardiac arrest before identification of the underlying etiology, underscoring the importance of aldosterone-to-renin ratio (ARR) screening in patients with unexplained treatment-resistant hypokalemia and arrhythmia regardless of blood pressure status. Early recognition and targeted treatment of PA in atypical presentations are essential to mitigate irreversible cardiovascular morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.